SpaceOAR

September 5, 2018

Higher Radiotherapy Doses But Fewer Treatment Sessions May Be Possible, Early Trial Data Suggest

News

Prostate cancer patients may benefit from a new form of radiation therapy that delivers larger doses per session but in a much shorter treatment course, and when used in combination ... Read more

June 25, 2018June 25, 2018

UT Southwestern Tests New Technique to Preserve Potency in Radiation Therapy Patients

News

UT Southwestern is conducting a multicenter clinical trial to test a new technique designed to spare nerves and arteries involved in sexual function to preserve potency in men receiving radiation ... Read more

October 19, 2017October 19, 2017

SpaceOAR Protects Surrounding Prostate Tissues from Radiation Therapy, Phase 2 Trial Shows

News

Augmenix’s SpaceOAR System can effectively protect the rectum of prostate cancer patients undergoing high dose stereotactic body radiation therapy (SBRT), a new prospective Phase 2 trial shows. The findings were recently reported ... Read more

September 11, 2017September 11, 2017

Long-Term Data Further Confirm SpaceOAR Hydrogel Quality-of-Life Benefits

News

Prostate cancer patients who received the SpaceOAR hydrogel before radiation therapy continue to report benefits five years after treatment, including better urinary and sexual function, a new study reported. The ... Read more

September 1, 2017September 1, 2017

NICE Approves SpaceOAR Hydrogel Use in UK

News

The National Institute for Health and Care Excellence (NICE) in the U.K. has issued a guidance for prostate cancer care that supports the use of SpaceOAR hydrogel as a protective barrier to reduce the ... Read more

June 28, 2017June 28, 2017

First N.Z. Prostate Cancer Patient Treated With SpaceOAR Technology

News

New Zealand’s Kathleen Kilgour Centre (KKC) has treated the country’s first patient with Augmenix‘s SpaceOAR system, a medical device that protects men from rectal complications after prostate cancer radiation therapy. Because the prostate and the rectum ... Read more

April 20, 2015November 18, 2016

Augmenix Announced Clearance Of Its SpaceOAR System For Prostate Cancer

News

Augmenix, Inc. recently announced that the FDA has approved the SpaceOAR System, the first product in the US receiving clearance as a spacer that protects the rectum in men undergoing prostate cancer (PCa) radiotherapy. ... Read more